跳至主要内容
临床试验/ITMCTR2026001660
ITMCTR2026001660进行中(未招募)Unknown

A Randomized Controlled Clinical Study on the Intervention of Chinese Herbal Compound Aromatherapy Combined with Acupuncture Therapy for Mild to Moderate Depression

Beijing Hospital of Traditional Chinese Medicine,Capital Medical University0 个研究点开始时间: 2026年8月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • Meets the diagnostic criteria for depression according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); aged 18–65 years; HAMD-17 score =7 and <24; no antidepressant treatment received within 2 weeks prior to enrollment; and voluntarily participates with signed informed consent.

排除标准

  • Individuals with suicidal ideation (HAMD-17 suicide item score >2); a prior diagnosis of intellectual disability, schizophrenia, bipolar disorder, substance abuse, or other psychiatric disorders; a history of organic brain disease or severe physical illness; patients with respiratory diseases; and pregnant patients.

研究者

发起方
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University

相似试验